Sundaram Senthil Vel 4
4 · Terns Pharmaceuticals, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Sundaram Senthil Vel
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-05-31$1.41/sh+2,111$2,977→ 9,770 total
Footnotes (1)
- [F1]Includes the purchase of 2,111 shares under the Terns Employee Stock Purchase Plan on May 31, 2023.